A research group at the Italian Institute of Technology (Istituto Italiano di Tecnologia - IIT) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The team designed the new molecule, called Apt1, using artificial intelligence tools and tested it in in vitro experiments, demonstrating its effectiveness in making tumour cells more vulnerable to chemotherapy drugs. When combined with drugs already in use, the molecule increases the effectiveness of anticancer therapies even at lower dosages than those normally given. The research study has been published in the scientific journal Nature Communications.

Summary:

• University of Ottawa researchers developed a dual-agent AI system that enables wireless networks to autonomously detect and defend against jamming attacks in real-time.

• The technology strengthens Canada's digital infrastructure by protecting critical services including emergency response, healthcare, transportation, and smart city applications.